Capecitabine enhances sensitivity to oxaliplatin in advanced gastric cancer and the effects on patients' FOXP1 and GGT levels
Capecitabine effectively enhanced the sensitivity of intermediate and advanced gastric cancer to oxaliplatin, improved the therapeutic effect, reduced the proportion of patients with low FOXP1 expression rate and serum GGT level, decreased the recurrence rate and ameliorated the prognosis of patients.
Authors
- Xinyu Guo (ORCID: https://orcid.org/0000-0002-7282-7379)
- Yi Liu (ORCID: https://orcid.org/0000-0002-7881-4675)
Institutions
- Zhengzhou Central Hospital (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-10-09
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e39152
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00